FeesSafety
Pluang+

Stifel partners with Anthropic to enhance its advisor Dashboard using AI technology Claude.

Market News
10 Nov 2026, 19:15 WIB
GlobeNewsWire
View Source
Bullish
Stifel partners with Anthropic to enhance its advisor Dashboard using AI technology Claude.

Stifel Financial Corporation announced a collaboration with Anthropic to upgrade its Dashboard platform used by financial advisors. This integration will incorporate Anthropic's AI tools, including Claude, to modernize the advisor workspace while maintaining the platform's familiar features. The move aims to improve advisor efficiency and client service, reflecting Stifel's commitment to leveraging technology for better financial advising. The partnership was revealed at Stifel's Blueprint 2026 innovation conference.

Stifel's collaboration with Anthropic is the story's subject, here is Pluang's market snapshot for Financials-sector US stocks. Of 142 priced stocks, 56 rose and 84 fell today. Notable movers include UPST at USD 19.80 with a -11.01% change and 100% buy order activity, AVAT at USD 1.00 up 10.50% with 91% buy orders, and MARA at USD 7.17 up 7.98% with 76% buy orders. This data is as of Nov 10, 2026 23:41 WIB.

More News

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...

Company Fundamentals
Neutral
37 minutes ago
EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...

Company Fundamentals
Neutral
37 minutes ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
1 hour ago
Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
1 hour ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App